Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Nvidias Latest Quarterly Report Seen as Consistent With Analyst Expectations Bessent Predicts Substantial Disinflation as Fed Transition Under Warsh Begins Snowflake Boosts Annual Product Revenue Forecast as Enterprise AI Adoption Accelerates May PMI Reflects Gains in Manufacturing Slump in Services Can November Soybeans Challenge Contract Highs Strong Crush Demand and Seasonal Strength Suggest Potential MLI Q1 2026 Earnings EPS Surges Past Estimates by 238 as Strong Execution Drives Results GFL Q1 2026 Earnings EPS Misses Estimates Amidst Cost Pressures FORR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines LENZ Q1 2026 Earnings EPS Misses Estimates as Development Costs Persist BitGo Holdings Inc BTGO Q1 2026 Earnings Deep EPS Miss Sends Shares Down 107 SB Financial Group Inc SBFG Holds Steady at 215 as Key Levels Provide Bounds Biogen BIIB Trading Flat at 19356 Key Levels in Focus EZGO Technologies EZGO Shares Slide 926 as Stock Tests Key Support at 140 Aclaris Therapeutics Holds Steady Near MidRange as Traders Eye Key Support and Resistance Barclays Adjusts Price Target for Energy Transfer Citing Potential Undervaluation Vertiv VRT Launches PowerUPS 100 Standby Series in North America to Address Growing Backup Power Demand Leonardo Secures 320 Million Naval Contract with Abu Dhabi Ship Building for Kuwait Patrol Vessels Soaring Treasury Yields Reshape Consumer Finances What It Means for Borrowers and Savers Context Therapeutics CNTX Surges Over 8 Amid Renewed Buying Interest Above Key Support RiverNorth Opportunistic Municipal Income Fund RMI Posts Modest Gain as Price Holds Near Key Resistance Muzero Acquisition Corp MUZE Holds Steady at 992 Trading in Tight Range Sharps Technology Inc Warrant STSSW Holds Steady at 004 Amid Low Volatility Figure Technology Solutions FIGR Edges Lower as Shares Approach Key Support Nasus Pharma NSRX Gains 389 as Biotech Investors Eye Key Resistance